David Dexter, MD
Vascular Surgery · Norfolk, VANPI 1649306853
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 51 manufacturers reported payments, led by Johnson & Johnson at 35.4% of the total. Reporting peaked in 2019 at $143,004 and has fallen 89.4% since, to $15,227 in 2025. Among vascular surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 981 payments — averaging $412.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$143K
- Boston Scientific$56K
- Penumbra, Inc.$49K
- Inari Medical, Inc.$33K
- Bard Peripheral Vascular, Inc.$24K
- Medtronic$17K
- plus $83K from 45 others
Across 614 payments — averaging $3103.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mercator Medsystems, Inc.$396K
- Inari Medical, Inc.$286K
- Shockwave Medical, Inc$282K
- Penumbra, Inc.$212K
- Medtronic$182K
- Merit Medical Systems Inc$136K
- plus $412K from 14 others
What the payments were for
- Consulting fees$90,34222%
- Speaking & faculty fees$200,62550%
- Travel & lodging$54,99414%
- Food & beverage$58,27614%
- Education$1570%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$141,599
- Indigo$79,392
- FlowTriever$20,951
- ClotTriever$20,951
- VENOVO$17,703
- GENERAL VASCULAR INTERVENTION$17,119
- OptiCross 35$15,000
- CT THROMBECTOMY SYSTEM KIT$13,099
- Diamondback Peripheral$9,181
- GENERAL - THERAPIES$8,364
- FLOWTRIEVER CATHETER, S$8,136
- Stravix$7,178
- Grafix$7,178
- GrafixPL$7,178
- Peripheral Orbital Atherectomy System$6,246
- Diamondback Coronary$6,120
- VENOUS WALLSTENT$5,664
- ANGIOJET$4,500
- Relay Grafts$4,317
- Rotarex$4,200
How this compares
$404,394 in reported general payments places this provider in the 95th percentile of 143 vascular surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 161 | $181,206 |
| EliquisApixaban | 56 | $53,124 |
| BrilintaTicagrelor | 32 | $23,699 |
| Prasugrel Hcl | 23 | $2,270 |
| ClopidogrelClopidogrel Bisulfate | 145 | $1,399 |
| Atorvastatin Calcium | 26 | $386 |
| Cilostazol | 42 | $352 |
| Rosuvastatin Calcium | 22 | $139 |
| Gabapentin | 16 | $120 |
| Oxycodone Hcl | 16 | $58 |
| Prednisone | 16 | $14 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $142,976 | $181,206161 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 143 vascular surgery providers in Virginia.
Other vascular surgery in Norfolk
- Animesh RathoreNorfolk$83K
- Deepak DeshmukhNorfolk$37K
- Patrick SowaNorfolk$22K
- Emidio Germano da Silva NetoNorfolk$20K
- Jean PannetonVirginia Beach$1.3M
- John DeitrickRichmond$684K
- Rasesh ShahChesapeake$465K
- Samuel SteermanVirginia Beach$252K
- Joseph BabrowiczFairfax$202K
- Joshua AdamsRoanoke$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.